Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Common Equity (2016 - 2025)

Chemours has reported Common Equity over the past 12 years, most recently at $250.0 million for Q4 2025.

  • Quarterly results put Common Equity at $250.0 million for Q4 2025, down 56.29% from a year ago — trailing twelve months through Dec 2025 was $250.0 million (down 56.29% YoY), and the annual figure for FY2025 was $250.0 million, down 56.29%.
  • Common Equity for Q4 2025 was $250.0 million at Chemours, down from $276.0 million in the prior quarter.
  • Over the last five years, Common Equity for CC hit a ceiling of $1.8 billion in Q1 2024 and a floor of -$15.0 million in Q2 2024.
  • Median Common Equity over the past 5 years was $876.0 million (2021), compared with a mean of $877.0 million.
  • Biggest five-year swings in Common Equity: plummeted 101.85% in 2024 and later skyrocketed 1633.33% in 2025.
  • Chemours' Common Equity stood at $1.1 billion in 2021, then rose by 2.22% to $1.1 billion in 2022, then crashed by 34.81% to $721.0 million in 2023, then decreased by 20.67% to $572.0 million in 2024, then plummeted by 56.29% to $250.0 million in 2025.
  • The last three reported values for Common Equity were $250.0 million (Q4 2025), $276.0 million (Q3 2025), and $230.0 million (Q2 2025) per Business Quant data.